Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an uncommon cardiomyopathy characterized by fibroadiposis replacing cardiac myocytes, predominantly in the right ventricle. The clinical phenotype is characterized by cardiac arrhythmias, sudden cardiac death, and heart failure. The molecular genetic basis of ARVC is partially known. Mutations in DSP (desmoplakin), JUP (plakoglobin), PKP2 (plakophilin 2), DSG2 (desmoglein 2), and DSC2 (desmocollin 2) are responsible for approximately half of the cases. Mutations in TMEM43 and TGFB3, encoding transmembrane protein 43 and transforming growth factor β3, respectively, also have been associated with ARVC. The molecular pathogenesis of ARVC has at least two components. The first component is fibroadiposis, which is the characteristics hallmark of the disease. The second is cardiac dysfunction, which is primarily due to impaired myocyte-to-myocyte attachment. The pathogenesis of fibroadiposis involves partial nuclear translocation of plakoglobin (PG) and subsequent suppression of canonical Wnt signaling, which is involved in the development of the right ventricle and its outflow tract, the predominant sites of involvement in ARVC. Suppression of the canonical Wnt signaling results in a switch to adipogenesis in the second heart field progenitor cells. Accordingly, ARVC is a disease of cardiac progenitor cells that have gone awry and differentiated to adipocytes.
Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of Medicine, University of Texas Health Sciences Center at Houston, Texas Heart Institute at St. Luke's Epsicopal Hospital, 6770 Bertner Street, Suite C900A, Houston, TX 77030, USA.
Raffaella
R
Lombardi
A J
AJ
Marian
D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D006801:Humans; D013234:Stem Cells / Q000378:metabolism*
Circulation. 2006 Apr 4;113(13):1650-8
16567567
Hum Mol Genet. 2001 Feb 1;10(3):189-94
11159936
Science. 2000 Aug 11;289(5481):950-3
10937998
J Am Coll Cardiol. 2003 Jul 16;42(2):319-27
12875771
Am J Med. 1990 Nov;89(5):588-96
2239978
Circulation. 2005 Aug 2;112(5):636-42
16061754
Cardiovasc Res. 2005 Feb 1;65(2):366-73
15639475
Europace. 2010 Jun;12(6):861-8
20400443
Circ Res. 2009 May 8;104(9):1076-84
19359597
Am J Hum Genet. 2008 Apr;82(4):809-21
18313022
Circulation. 2003 Dec 16;108(24):3000-5
14662701
J Am Acad Dermatol. 1998 Sep;39(3):418-21
9738775
Cardiology. 2009;113(1):28-34
18957847
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9319-24
17519332
Am J Hum Genet. 2006 Dec;79(6):1081-8
17186466
Am J Hum Genet. 2006 Nov;79(5):978-84
17033975
Hum Mol Genet. 2000 Nov 1;9(18):2761-6
11063735
BMC Med Genet. 2007 Oct 26;8:65
17963498
J Am Coll Cardiol. 2008 Dec 16;52(25):2175-87
19095136
Circulation. 2001 Jan 16;103(2):196-200
11208676
Am J Cardiol. 1995 Jul 15;76(3):148-52
7611149
Nat Genet. 2004 Nov;36(11):1162-4
15489853
Circulation. 2006 Mar 7;113(9):1171-9
16505173
JAMA. 1996 Jul 17;276(3):199-204
8667563
Circ Res. 2010 Sep 17;107(6):700-14
20847325
N Engl J Med. 1988 Jan 21;318(3):129-33
3336399
Lancet. 2000 Jun 17;355(9221):2119-24
10902626
J Clin Invest. 2006 Jul;116(7):2012-21
16823493